These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 28297587)
21. Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation. Liu Q; Pedersen OZ; Peng J; Couture LA; Rao MS; Zeng X Cytotherapy; 2013 Aug; 15(8):999-1010. PubMed ID: 23664011 [TBL] [Abstract][Full Text] [Related]
22. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. Rössler R; Boddeke E; Copray S Neuroscience; 2010 Oct; 170(2):417-28. PubMed ID: 20643196 [TBL] [Abstract][Full Text] [Related]
23. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model. Steinbeck JA; Choi SJ; Mrejeru A; Ganat Y; Deisseroth K; Sulzer D; Mosharov EV; Studer L Nat Biotechnol; 2015 Feb; 33(2):204-9. PubMed ID: 25580598 [TBL] [Abstract][Full Text] [Related]
24. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Cooper O; Hargus G; Deleidi M; Blak A; Osborn T; Marlow E; Lee K; Levy A; Perez-Torres E; Yow A; Isacson O Mol Cell Neurosci; 2010 Nov; 45(3):258-66. PubMed ID: 20603216 [TBL] [Abstract][Full Text] [Related]
26. Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo. Moon J; Schwarz SC; Lee HS; Kang JM; Lee YE; Kim B; Sung MY; Höglinger G; Wegner F; Kim JS; Chung HM; Chang SW; Cha KY; Kim KS; Schwarz J Stem Cells Transl Med; 2017 Feb; 6(2):576-588. PubMed ID: 28191758 [TBL] [Abstract][Full Text] [Related]
27. Forced LMX1A expression induces dorsal neural fates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons. Rifes P; Kajtez J; Christiansen JR; Schörling A; Rathore GS; Wolf DA; Heuer A; Kirkeby A Stem Cell Reports; 2024 Jun; 19(6):830-838. PubMed ID: 38759646 [TBL] [Abstract][Full Text] [Related]
28. FolR1: a novel cell surface marker for isolating midbrain dopamine neural progenitors and nascent dopamine neurons. Gennet N; Tamburini C; Nan X; Li M Sci Rep; 2016 Sep; 6():32488. PubMed ID: 27580818 [TBL] [Abstract][Full Text] [Related]
31. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells. Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202 [TBL] [Abstract][Full Text] [Related]
32. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells. Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336 [TBL] [Abstract][Full Text] [Related]
33. Clinical translation of stem cell transplantation in Parkinson's disease. Lindvall O J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959 [TBL] [Abstract][Full Text] [Related]
34. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD). Kirkeby A; Parmar M; Barker RA Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228 [TBL] [Abstract][Full Text] [Related]
35. Transcriptional comparison of human induced and primary midbrain dopaminergic neurons. Xia N; Zhang P; Fang F; Wang Z; Rothstein M; Angulo B; Chiang R; Taylor J; Reijo Pera RA Sci Rep; 2016 Feb; 6():20270. PubMed ID: 26842779 [TBL] [Abstract][Full Text] [Related]
36. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Doi D; Samata B; Katsukawa M; Kikuchi T; Morizane A; Ono Y; Sekiguchi K; Nakagawa M; Parmar M; Takahashi J Stem Cell Reports; 2014 Mar; 2(3):337-50. PubMed ID: 24672756 [TBL] [Abstract][Full Text] [Related]
37. A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells. Niclis JC; Gantner CW; Hunt CPJ; Kauhausen JA; Durnall JC; Haynes JM; Pouton CW; Parish CL; Thompson LH Stem Cell Reports; 2017 Sep; 9(3):868-882. PubMed ID: 28867345 [TBL] [Abstract][Full Text] [Related]
38. Understanding Parkinson's Disease through the Use of Cell Reprogramming. Playne R; Connor B Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784 [TBL] [Abstract][Full Text] [Related]
39. Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models. Fathi A; Mirzaei M; Dolatyar B; Sharifitabar M; Bayat M; Shahbazi E; Lee J; Javan M; Zhang SC; Gupta V; Lee B; Haynes PA; Baharvand H; Salekdeh GH Mol Cell Proteomics; 2018 Sep; 17(9):1670-1684. PubMed ID: 29848781 [TBL] [Abstract][Full Text] [Related]
40. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside. Wang M; Ling KH; Tan JJ; Lu CB Cells; 2020 Jun; 9(6):. PubMed ID: 32570916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]